Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme.

Xin, Yiqiao; Davies, Andrew; Briggs, Andrew; McCombie, Louise; Messow, C Martina; Grieve, Eleanor; Leslie, Wilma S; Taylor, Roy; Lean, Michael EJ; (2020) Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. DIABETOLOGIA, 63 (10). pp. 2112-2122. ISSN 0012-186X DOI: https://doi.org/10.1007/s00125-020-05224-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1007/s00125-020-05224-2

Abstract

Share

Download

Filename: Xin2020_Article_Type2DiabetesRemission2YearWit.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar